Parametric Cardiac Imaging with 18F-Flutemetamol PET to Evaluate the Impact of Tafamidis in Patients with Transthyretin Cardiac Amyloidosis.

Saved in:
Bibliographic Details
Title: Parametric Cardiac Imaging with 18F-Flutemetamol PET to Evaluate the Impact of Tafamidis in Patients with Transthyretin Cardiac Amyloidosis.
Authors: Liu, Qiong1 (AUTHOR), Shi, Tiantian2,3 (AUTHOR), Gravel, Paul4 (AUTHOR), Sharma, Aakanksha2 (AUTHOR), De Freitas, Cinthia2 (AUTHOR), Fazzone-Chettiar, Ramesh2 (AUTHOR), Van Laere, Koen5 (AUTHOR), Baldick, Andrea2 (AUTHOR), Kattan, Cesia Gallegos2 (AUTHOR), Guo, Xueqi1 (AUTHOR), Guo, Liang1 (AUTHOR), Xie, Huidong1 (AUTHOR), Chen, Xiongchao1 (AUTHOR), Zhou, Bo1 (AUTHOR), Liu, Yi-Hwa2 (AUTHOR), Carson, Richard E.1,4 (AUTHOR), Liu, Chi1,4 (AUTHOR) chi.liu@yale.edu, Miller, Edward2,4 (AUTHOR) edward.miller@yale.edu
Source: Journal of Nuclear Medicine. May2026, Vol. 67 Issue 5, p780-787. 8p.
Database: Engineering Source
Full text is not displayed to guests.
Description
ISSN:01615505
DOI:10.2967/jnumed.125.270003